SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

CUSIP: 78397T202

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
-212,515
SEC-reported price per share
$3.10
Number of holders
21
Value change
-$923,501
Number of buys
7
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
226,597,678

Security key

78397T202

Report period

Q2 2024

Institutions

21

Top holders

10

Ownership snapshot

Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Edward D. Hamilton
Disclosed value leader
Edward D. Hamilton
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $9,348,396 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Edward D. Hamilton has the largest disclosed position value at $9.35M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Edward D. Hamilton's linked filing trail.
Disclosed position value Top 5
Edward D. Hamilton $9.35M
Ilan Katz $2.68M
RTW INVESTMENTS, LP $4.17M
BVF INC/IL $4.17M
MARSHALL WACE, LLP $2.08M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Edward D. Hamilton
3/4/5
10%+ Owner
—
mixed-class rows
$9,348,396
9,456,382 shares
mixed-class rows
— 22 Oct 2021
Ilan Katz
3/4/5
Director, 10%+ Owner
—
denominator unverified
$2,683,406
3,049,325 shares
— 13 Oct 2021
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$4,166,934
917,827 shares
— 31 Mar 2024
BVF INC/IL
13F
Company
13F
—
denominator unverified
$4,166,930
917,826 shares
— 31 Mar 2024
MARSHALL WACE, LLP
13F
Company
13F
—
denominator unverified
$2,084,623
459,168 shares
— 31 Mar 2024
Sessa Capital IM, L.P.
13F
Company
13F
—
denominator unverified
$2,081,395
458,457 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
21
Shares
3,127,151
Rows available
21
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q4 2025 Across Filers

Q4 2025 holders
48
Q2 2024 holders
21
Holder diff
-27
Investor Q4 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q4 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .